Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

BACKGROUND: Despite the increasing use of adjuvant bisphosphonates for early stage breast cancer (EBC), little is known about the patient experience with such treatments. A patient survey was performed to identify current prescribing practices, perceptions around the role of treatment, the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: McGee, Sharon, AlZahrani, Mashari, Stober, Carol, Ng, Terry L., Cole, Katherine, Larocque, Gail, Awan, Arif, Sehdev, Sandeep, Hilton, John, Vandermeer, Lisa, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930351/
https://www.ncbi.nlm.nih.gov/pubmed/33680749
http://dx.doi.org/10.1016/j.jbo.2021.100351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930351/
https://www.ncbi.nlm.nih.gov/pubmed/33680749
http://dx.doi.org/10.1016/j.jbo.2021.100351

Ejemplares similares